Live Quote · OTCBTHEHealthcare· Biotechnology

Boston Therapeutics, Inc.

$0.01 0.00%(+$0.00)
TickerSpark Score
35/100
Weak
20
Valuation
40
Profitability
55
Growth
32
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BTHE research report →

52-Week Range7% of range
Low
$0.01
Current
$0.01
High
$0.07
Company Overviewwww.bostonti.com

About the company

Founded in 2009 and headquartered in Lawrence, Massachusetts, Boston Therapeutics, Inc. operates as a pre-clinical and clinical-stage pharmaceutical development firm. The company specializes in the development, manufacturing, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements within the United States.

CEO
Chi-Heng Cheng
IPO
2012
HQ
Lawrence, MA, US
Valuation
Market Cap
$0
P/E
-1.22
P/S
0.00
P/B
-0.13
EV/EBITDA
-10.11
Div Yield
0.00%
Profitability
Gross Margin
-243.20%
Op Margin
-8418.32%
Net Margin
-9724.54%
ROE
11.17%
ROIC
20.99%
Growth & Income
Revenue
$9.34K · -42.83%
Net Income
$-907,883 · 75.42%
EPS
$-0.01 · 77.22%
Op Income
$-785,934
FCF YoY
34.42%
Performance & Tape
52W High
$0.07
52W Low
$0.01
50D MA
$0.01
200D MA
$0.02
Beta
-0.78
Avg Volume
169.80K

Get TickerSpark's AI analysis on BTHE

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Feb 2, 18RAUSCH CARL Wbuy2,000,000
Feb 2, 18RAUSCH CARL Wbuy1,000,000
Sep 15, 11RAUSCH CARL Wother1,500,000
Aug 12, 16RAUSCH CARL Wother6,000,000
Mar 25, 15RAUSCH CARL Wother500,000
May 15, 15CONAWAY DALE Hbuy5,000
May 15, 15PLATT DAVIDbuy1,000
May 14, 15PLATT DAVIDbuy5,000
Sep 25, 14ESBER HENRY JEMILother6,000
Mar 18, 15ESBER HENRY JEMILbuy9,000
Coverage · BTHE

Our BTHE coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on BTHE yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate BTHE report →
Internal Compare

Similar companies

Peers in the same neighborhood.